About 200 reports

The autoimmune disease diagnostics market is expected to register a CAGR of nearly 8.3% during the forecast period. The rising awareness about autoimmune diseases through programs of research, education, support, and advocacy is a key factor boosting the usage rates of autoimmune disease diagnostics, globally. The United States has the highest...

  • Autoimmune Disease
  • APAC
  • Europe
  • South Africa
  • Health Expenditure
  • Diabetes Prevalence

Major players in the autoimmune disease diagnosis market are Thermo Fisher Scientific, Siemens Healthineers, Abbott, Danaher, Bio-Rad Laboratories, Trinity Biotech, HYCOR Biomedical, EUROIMMUN AG, AESKU GROUP GMBH & CO.KG and F. Hoffmann-La Roche Ltd. The global autoimmune disease diagnosis market is expected to grow from $4.55...

  • Autoimmune Disease
  • United States

Autoimmune Disease Diagnostics market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Autoimmune Disease Diagnostics Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Autoimmune Disease Diagnostics types,...

  • Diagnostics
  • Autoimmune Disease
  • World

Major players in the autoimmune disease diagnosis market are Thermo Fisher Scientific, Siemens Healthineers, Abbott, Danaher, Bio-Rad Laboratories, Trinity Biotech, Hycor Biomedical, Euroimmun AG, and Aesku Group GMBH & CO. KG. The global autoimmune disease diagnosis market is expected to grow from $3.38 billion in 2020 to $4.15 billion...

  • Autoimmune Disease
  • World
  • United States
  • United Kingdom

Autoimmune Disease Diagnostic Market Size Global Forecast 2021-2027, Industry Trends, Impact of COVID-19, Opportunity Company Analysis Autoimmune diseases arise when the immune system fails to recognize the body’s tissues and cells as "self" and alternatively mounts an immune response against the tissues, considering...

  • Autoimmune Disease
  • World
  • APAC
  • Disposable Income
  • Auto-Immune Diseases Prevalence

Report Scope: The report will provide details about autoimmune disease diagnostics used in the treatment of autoimmune disease and how the market has been influenced by the pandemic of COVID-19.This report will also highlight the current and future market potential of autoimmune disease diagnostics with detailed analyses...

  • Autoimmune Disease
  • World
  • Overweight Prevalence

Autoimmune Disease Diagnostics Market Report Overview Autoimmune Disease Diagnostics market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Autoimmune Disease Diagnostics market types and applications. It is a focused study on Autoimmune Disease...

  • Diagnostics
  • Autoimmune Disease
  • World
  • Health Provider Density

Abstract: - Global Autoimmune Disease Diagnosis Market to Reach $6 Billion by 2027 - Amid the COVID-19 crisis, the global market for Autoimmune Disease Diagnosis estimated at US$3.6 Billion in the year 2020, is projected to reach a revised size of US$6 Billion by 2027, growing at a CAGR of 7.6% over the analysis period...

  • Autoimmune Disease
  • World
  • China
  • United States

The global autoimmune disease diagnosis market reached a value of US$ 4.4 Billion in 2020. An autoimmune disease refers to a condition wherein the immune system attacks and destroys healthy cells, tissues, and organs of the body. In the longer run, it can also lead to abnormal growth of an organ and changes in organ function. Currently, more...

  • Autoimmune Disease
  • World

The global autoimmune disease diagnosis market size is projected to register a CAGR of 8.9% during the forecast period. The global autoimmune disease diagnosis market size is projected to reach USD 6.3 billion by 2025 from USD 4.1 billion in 2020, at a CAGR of 8.9%. Growth in this industry is driven by the rising incidence...

  • Autoimmune Disease
  • World
  • APAC
  • Europe
  • Health Expenditure
  • Auto-Immune Diseases Prevalence

Abstract: - Global Autoimmune Disease Therapeutics Market to Reach $139.4 Billion by 2027 - Amid the COVID-19 crisis, the global market for Autoimmune Disease Therapeutics estimated at US$115.1 Billion in the year 2020, is projected to reach a revised size of US$139.4 Billion by 2027, growing at a CAGR of 2.8% over...

  • Autoimmune Disease
  • World
  • China
  • United States

Autoimmune Disease Diagnostics Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026 The study predicts the short term and long term trends that can shape up the future of the Autoimmune Disease Diagnostics market including the COVID-19...

  • Diagnostics
  • Autoimmune Disease
  • APAC
  • Central America

Major players in the autoimmune disease diagnosis market are Thermo Fisher Scientific, Siemens Healthineers, Abbott, Danaher, Bio-Rad Laboratories, Trinity Biotech, HYCOR Biomedical, EUROIMMUN AG, and AESKU GROUP GMBH & CO. KG. The global autoimmune disease diagnosis market is expected to decline from $3.58 billion in 2019 to $3.08...

  • Autoimmune Disease
  • United States

Autoimmune Disease Diagnostics Market Research Report: By Product (Consumables and Assay Kits, Instruments), Test Type (Routine Laboratory, Inflammatory Marker, Autoantibodies and Immunology, Human Leukocyte Antigen, Cytokine, Flow Cytometry), Application (Rheumatoid Arthritis, Multiple Sclerosis, Systemic Lupus Erythematosus, Sjögren’s...

  • Autoimmune Disease
  • Diagnostics
  • North America
  • World

Global Autoimmune Disease Diagnostics Market 2021-2025 The analyst has been monitoring the autoimmune disease diagnostics market and it is poised to grow by $ 1.98 bn during 2021-2025, progressing at a CAGR of almost 9% during the forecast period. Our report on autoimmune disease diagnostics market provides a holistic analysis,...

  • Autoimmune Disease
  • Diagnostics
  • World

Auto-Immune Diseases Diagnostic Tests - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Auto-Immune Diseases Diagnostic Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Auto-Immune Diseases Diagnostic Tests pipeline...

  • Autoimmune Disease
  • Diagnostics

This report is 80% complete and can be delivered within three working days post order confirmation and will include the latest impact analysis of Covid-19 in 2020 and forecast. Global Autoimmune Disease Diagnostics Market By Type (Systemic, Organ-Specific), By Sex (Male, Female), By Age (0-15, 15-44, 44+), By Factors...

  • Diagnostics
  • Autoimmune Disease
  • World

The injectable drugs market is expected to register a CAGR of nearly 11.1% during the forecast period. With an upsurge in the number of chronic diseases like diabetes and cancer, the need for drug delivery systems has risen substantially in the market. From the past one era of healthcare, biologics are increasingly becoming the driving...

  • Pharmaceutical
  • Infectious Disease
  • Biopharmaceutical
  • Monoclonal Antibody
  • Injectable Delivery
  • Cardiovascular Disease
  • Autoimmune Disease
  • Protein Therapy
  • World
  • APAC
  • Europe
  • Africa
  • South Africa
  • Drug Approval
  • Diabetes Prevalence

Report Scope: The report will provide details about autoimmune disorder therapies used in the treatment of autoimmune disease and how it has been influenced by the pandemic of COVID-19.This report will also highlight the current and future market potentiality of autoimmune disorder therapies with detailed analyses of the...

  • Autoimmune Disease
  • World
  • Overweight Prevalence

The North America wearable injectors Market is projected to reach US$ 5767.51 million by 2027 from US$ 2370.52 million in 2019. The market is estimated to grow at CAGR of 11.9% from 2020 to 2027. The growth of the market is driven by the factors such as, increasing chronic diseases prevalence, technological advancements and design development,...

  • Drug Delivery
  • Cardiovascular Disease
  • Diabetes
  • Autoimmune Disease
  • Infectious Disease
  • North America
  • Chronic Disease Prevalence
  • Cancer Incidence

The Asia Pacific Wearable Injectors market is expected to reach US$ 2939.97 million by 2027 from US$ 1160.40 million in 2019. The market is estimated to grow at CAGR of 12.4% from 2020 to 2027. The growth of the market is driven by the factors such as, increasing chronic diseases prevalence, technological advancements and design development,...

  • Drug Delivery
  • Cardiovascular Disease
  • Autoimmune Disease
  • Hospital
  • APAC
  • Chronic Disease Prevalence
  • Cause-Specific Mortality Rate

The Europe wearable injectors market is expected to reach US$ 3586.82 million in 2027 from US$ 1539.88 million in 2019. The market is estimated to grow with a CAGR of 11.3 % from 2020 to 2027. The growth of the market is driven by the factors such as, increasing chronic diseases prevalence, technological advancements and design development,...

  • Drug Delivery
  • Cardiovascular Disease
  • Autoimmune Disease
  • Europe
  • Chronic Disease Prevalence
  • Cause-Specific Mortality Rate

Major players in the biosimilar interleukins market are MabPharm, Gedeon Richter, Bio-Thera Solutions, Sorrento Therapeutics/MabTech and Sunshine Guojian Pharmaceutical. The global biosimilar interleukins market is expected to grow from $1.42 billion in 2021 to $2.01 billion in 2022 at a compound annual growth rate (CAGR) of 40.9%....

  • Protein Therapy
  • Autoimmune Disease
  • World
  • Western Europe
  • France
  • United States
  • APAC

Major players in the biosimilar interleukins market are MabPharm, Gedeon Richter, Bio-Thera Solutions, Sorrento Therapeutics/MabTech, and Sunshine Guojian Pharmaceutical. The global biosimilar interleukins market is expected to grow from $1.03 billion in 2020 to $1.33 billion in 2021 at a compound annual growth rate (CAGR) of 29.1%....

  • Autoimmune Disease
  • Protein Therapy
  • World
  • United States
  • France
  • APAC

Global Autoimmune Partnering 2015 to 2022 provides the full collection of Autoimmune disease deals signed between the world’s pharmaceutical and biotechnology companies since 2015. Trends in Autoimmune partnering deals Financial deal terms for headline, upfront and royalty by stage of development Autoimmune partnering...

  • Autoimmune Disease
  • World

Global Therapeutic Vaccines Market 2020-2024 The analyst has been monitoring the therapeutic vaccines market and it is poised to grow by $ 3.78 bn during 2020-2024 progressing at a CAGR of 43% during the forecast period. Our reports on therapeutic vaccines market provides a holistic analysis, market size and forecast,...

  • Infectious Disease
  • Neurological Disorder
  • Cancer Immunotherapy
  • Autoimmune Disease
  • Research And Development
  • Vaccine
  • World

Major players in the biosimilar interleukins market are MabPharm, Gedeon Richter, Bio-Thera Solutions, Sorrento Therapeutics/MabTech and Sunshine Guojian Pharmaceutical. The global interleukins market is expected to grow from $0.83 billion in 2019 to $1.6 billion in 2020 at a compound annual growth rate (CAGR) of 93.0%. The slow growth...

  • Protein Therapy
  • Autoimmune Disease
  • United States
  • World

KEY FINDINGS The global alopecia (hair loss) treatment market is set to project a CAGR of 4.56% during the forecast period, 2021-2028. Stress, changing lifestyles, high consumption of tobacco & alcohol, unhealthy dietary habits, and rising autoimmune diseases drive the market growth. MARKET INSIGHTS Alopecia...

  • Autoimmune Disease
  • World

Global Anti-nuclear Antibody (ANA) Testing Market 2021-2025 The analyst has been monitoring the anti-nuclear antibody (ANA) testing market and it is poised to grow by $ 362.30 million during 2021-2025, progressing at a CAGR of about 7% during the forecast period. Our report on anti-nuclear antibody (ANA) testing market...

  • Autoimmune Disease
  • Clinical Diagnostic
  • Marketing Research
  • World

Abstract: What`s New for 2022? -Global competitiveness and key competitor percentage market shares -Market presence across multiple geographies - Strong/Active/Niche/Trivial -Online interactive peer-to-peer collaborative bespoke updates -Access to our digital archives and MarketGlass...

  • Healthcare
  • Arthritis
  • Autoimmune Disease
  • World
  • United States
  • Auto-Immune Diseases Prevalence
  • Health Expenditure